Abstract

Immunotherapy is one of the key strategies for cancer treatment. The cGAS-cGAMP-STING-IRF3 pathway of cytosolic DNA sensing plays a pivotal role in antiviral defense. We report that the STING activator cGAMP possesses significant antitumor activity in mice by triggering the STING-dependent pathway directly. cGAMP enhances innate immune responses by inducing production of cytokines such as interferon-β, interferon-γ, and stimulating dendritic cells activation, which induces the cross-priming of CD8+ T cells. The antitumor mechanism of cGAMP was verified by STING and IRF3, which were up-regulated upon cGAMP treatment. STING-deficiency dramatically reduced the antitumor effect of cGAMP. Furthermore, cGAMP improved the antitumor activity of 5-FU, and clearly reduced the toxicity of 5-FU. These results demonstrated that cGAMP is a novel antitumor agent and has potential applications in cancer immunotherapy.

Highlights

  • (STING) locating in the ER membrane14. cGAMP induces a conformational change of STING, leading to the recruitment and activation of protein kinase TBK1 at the signaling complex

  • The transfer of cGAMP by viruses may represent a defense mechanism to propagate immune responses to uninfected target cells29. cGAMP is a critical stimulator of cGAS-cGAMP-STING-interferon regulatory factor 3 (IRF3)-mediated innate immune responses and is a high affinity endogenous activator of STING, we reasoned that cGAMP should promote antitumor immune responses in addition to its antiviral activity

  • It has been demonstrated that cGAMP is an endogenous activator of STING and it is generated in mammalian cells by cGAS in response to double-strand DNA in the cytoplasm[13,19,30]

Read more

Summary

Introduction

(STING) locating in the ER membrane14. cGAMP induces a conformational change of STING, leading to the recruitment and activation of protein kinase TBK1 at the signaling complex. CGAMP induces a conformational change of STING, leading to the recruitment and activation of protein kinase TBK1 at the signaling complex. Recent studies showed that STING-dependent cytosolic DNA sensing can mediate innate immune recognition of immunogenic tumors, and promote type-I IFN dependent antitumor immunity after radiation therapy[18,19]. A novel cGAS-cGAMP-STING-IRF3 pathway of cytosolic sensing and signaling has been verified to mediate innate immune response, and plays pivotal roles in antiviral defense[27]. CGAMP is a critical stimulator of cGAS-cGAMP-STING-IRF3-mediated innate immune responses and is a high affinity endogenous activator of STING, we reasoned that cGAMP should promote antitumor immune responses in addition to its antiviral activity. Our results established a solid basis for the development of cGAMP as a potential new antitumor immunotherapy drug

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call